Notch1 directly induced CD133 expression in human diffuse type gastric cancers

CD133 is considered as a stem-like cell marker in some cancers including gastric cancers, and Notch1 signaling is known to play an important role in the maintenance and differentiation of stem-like cells. We aimed to investigate whether Notch1 signaling contributes to the carcinogenesis of gastric cancers and CD133 induction. CD133 expression was detected in 51.4% of diffuse type gastric cancers while it was not detected in intestinal type gastric cancers. Similarly, only poorly-differentiated gastric cancer cell lines expressed CD133 and activated-Notch1. Inhibiting Notch1 signaling resulted in decreased CD133 expression, side population cells, cell proliferation and anchorage independent cell growth. Chromatin immunoprecipitation suggested that this Notch1 dependent regulation of CD133 was caused by direct binding of activated-Notch1 to the RBP-Jκ binding site in the 5′ promoter region of CD133 gene. In addition, knocking down RBP-Jκ reduced CD133 induction in activated-Notch1 transfected cells. These findings suggested that Notch1 signaling plays an important role in the maintenance of the cancer stem-like phenotype in diffuse type gastric cancer through an RBP-Jκ dependent pathway and that inhibiting Notch1 signaling could be an effective therapy against CD133 positive diffuse type gastric cancers.

[1]  M. Carolan,et al.  Gastric cancer stem cells: evidence, potential markers, and clinical implications , 2016, Journal of Gastroenterology.

[2]  Jinbo Chen,et al.  Self-renewal of CD133hi cells by IL6/Notch3 signalling regulates endocrine resistance in metastatic breast cancer , 2016, Nature Communications.

[3]  Yufan Cheng,et al.  Identification of stem-like cells and clinical significance of candidate stem cell markers in gastric cancer , 2016, Oncotarget.

[4]  Yiming Li,et al.  CD133 overexpression correlates with clinicopathological features of gastric cancer patients and its impact on survival: A systematic review and meta-analysis , 2015, Oncotarget.

[5]  H. Atmaca,et al.  Expression profiling of stem cell signaling alters with spheroid formation in CD133high/CD44high prostate cancer stem cells , 2014, Oncology letters.

[6]  H. Lee,et al.  CD133 expression is correlated with chemoresistance and early recurrence of gastric cancer , 2012, Journal of surgical oncology.

[7]  Yang Jiang,et al.  Expressions of putative cancer stem cell markers ABCB1, ABCG2, and CD133 are correlated with the degree of differentiation of gastric cancer , 2012, Gastric Cancer.

[8]  C. Mathers,et al.  Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008 , 2010, International journal of cancer.

[9]  Thomas Kirchner,et al.  The cancer stem cell marker CD133 has high prognostic impact but unknown functional relevance for the metastasis of human colon cancer , 2009, The Journal of pathology.

[10]  T. Shimosegawa,et al.  Helicobacter pylori induces gastric mucosal intestinal metaplasia through the inhibition of interleukin-4-mediated HMG box protein Sox2 expression. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[11]  S. Artavanis-Tsakonas,et al.  Notch and Wnt signals cooperatively control cell proliferation and tumorigenesis in the intestine , 2009, Proceedings of the National Academy of Sciences.

[12]  B. Alman,et al.  Side population cells in human cancers. , 2008, Cancer letters.

[13]  Tomohiro Watanabe,et al.  Notch1 Signaling and Regulatory T Cell Function , 2008, The Journal of Immunology.

[14]  C. D. Salcido,et al.  Brca1 breast tumors contain distinct CD44+/CD24- and CD133+ cells with cancer stem cell characteristics , 2008, Breast Cancer Research.

[15]  Göran Karlsson,et al.  Signaling pathways governing stem-cell fate. , 2008, Blood.

[16]  P. Correa,et al.  Carcinogenesis of Helicobacter pylori. , 2007, Gastroenterology.

[17]  I. Ng,et al.  Identification and characterization of tumorigenic liver cancer stem/progenitor cells. , 2007, Gastroenterology.

[18]  L. Ricci-Vitiani,et al.  Identification and expansion of human colon-cancer-initiating cells , 2007, Nature.

[19]  D. Stearns,et al.  Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors. , 2006, Cancer research.

[20]  W. Hahn,et al.  Roots and stems: stem cells in cancer , 2006, Nature Medicine.

[21]  M. Little,et al.  A Side Order of Stem Cells: The SP Phenotype , 2006, Stem cells.

[22]  Hans Clevers,et al.  Notch/γ-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells , 2005, Nature.

[23]  S. Artavanis-Tsakonas,et al.  Notch signals control the fate of immature progenitor cells in the intestine , 2005, Nature.

[24]  T. Koike,et al.  The polymorphism interleukin 8 −251 A/T influences the susceptibility of Helicobacter pylori related gastric diseases in the Japanese population , 2005, Gut.

[25]  L. Liaw,et al.  Soluble Jagged 1 Represses the Function of Its Transmembrane Form to Induce the Formation of the Src-dependent Chord-like Phenotype* , 2001, The Journal of Biological Chemistry.

[26]  S. Kitano,et al.  Pathology and prognosis of gastric carcinoma , 2000, Cancer.

[27]  R. Callahan,et al.  Identification of a novel NOTCH-4/INT-3 RNA species encoding an activated gene product in certain human tumor cell lines , 2000, Oncogene.

[28]  R. Caruso.  The histogenesis of mucinous adenocarcinoma of the stomach from observations in early gastric cancer. , 1999, Annals of diagnostic pathology.

[29]  S. Ming.  Cellular and molecular pathology of gastric carcinoma and precursor lesions: A critical review , 1998, Gastric Cancer.

[30]  P. Laurén,et al.  THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. , 1965, Acta pathologica et microbiologica Scandinavica.

[31]  M. Huang,et al.  Cisplatin selects for multidrug-resistant CD133+ cells in lung adenocarcinoma by activating Notch signaling. , 2013, Cancer research.